Disease Control Data, nr-axSpA

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study

Safety Profile, Axial Spondyloarthritis

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis, Arthritis Research & Therapy

Improving the design of RCTs in non-radiographic axial spondyloarthritis

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO, Arthritis Research & Therapy

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort

Raising the Bar for Optimal Management of Axial Spondyloarthritis - European Medical Journal

Disease Control Data, nr-axSpA

Frontiers Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis